Data protection Impressum

Newsroom

Geneva Business School launches Switzerland’s first MBA in Biotech Management, blending business strategy with biotech innovation.

Geneva Business School launches Switzerland’s first MBA in Biotech Management

4 August 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (July 2025)

4 August 2025

Geneva reaffirms its global standing by securing 5th place in the 2025 edition of the Economist Intelligence Unit’s (EIU) Global Liveability Index, highlighting the region’s continued excellence in quality of life, infrastructure, and public services.

Geneva ranks 5th in the world’s most liveable cities in 2025

16 July 2025

Fribourg Growth Hub, an 8-part video series featuring Jerry Krattiger, Managing Director of the Fribourg Development Agency, explores the diverse economic sectors that make Fribourg the "growth hub of Switzerland. »

Fribourg: The Growth Hub of Switzerland – A Video Series

Swiss start-ups raised CHF 1.47 billion in the first half of 2025, with biotech and fintech driving growth despite fewer deals and cautious investor sentiment.

Swiss start-ups attract CHF 1.47 billion in first half of 2025

15 July 2025

Bern-based medtech Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision and reduce unnecessary surgeries.

Compremium launches human study for non-invasive thyroid cancer diagnostic

15 July 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

CREAL has raised USD 8.9 million to boost AR and vision care tech with ZEISS, advancing light field displays for immersive, eye-friendly digital experiences.

CREAL raises USD 8.9 million to advance AR and vision care innovation

14 July 2025

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

1 2 3 4 5 6 … 144